Autopsy report · NCT02594943

Endodrill vs. Conventional Biopsy. Evaluation of Diagnostic Capacity in Diffuse Gastric Cancer

“Too narrow inclusion criteria. Impossible to recruit patients.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Region Skane

Sponsor type

University, hospital or other

Conditions

Stomach Neoplasms

Interventions

Boston Scientific Large Capacity with needle Biopsy; Endodrill 1A (BIBBInstruments, Lund, Sweden)

Participants

0

Trials that died the same way

• RCVS: The Rational Approach to Diagnosis and Treatment
  “Failure to recruit patients meeting inclusion criteria.” (86% match in meaning)
• Loading Dose or Standard Dose of Intravenous Ibandronate in Treating Patients With Lung Cancer and Skeletal Metastasis
  “It is too difficult to recruit suitable patients.” (81% match in meaning)
• A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection
  “Unable to recruit patients.” (79% match in meaning)
• Neuropsychological Effects of Hydrocortisone in Patients With Partial Adrenal Insufficiency
  “Insufficient recruitment of suitable patients.” (78% match in meaning)
• Huaier Granule for Prevention of Disease Progression of Hepatocarcinoma After Non-radical Hepatectomy
  “difficult to recruit patients” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.